Brian Unangst
About Brian Unangst
Brian Unangst is the Executive Director and Cell Therapy Clinical Manufacturing Network Lead at Bristol Myers Squibb in Warren, NJ, with extensive experience in pharmaceutical and biologics production.
Executive Director at Bristol Myers Squibb
Brian Unangst currently holds the position of Executive Director- Cell Therapy Clinical Manufacturing Network Lead at Bristol Myers Squibb. Based in Warren, New Jersey, Brian leads the cell therapy manufacturing network at the company, overseeing critical aspects of its clinical operations.
Past Roles at Bristol Myers Squibb
Brian Unangst has held multiple significant roles at Bristol Myers Squibb. From 2022 to 2023, he served as Executive Director- General Manager in Warren, New Jersey. Prior to that, Brian was the Senior Director- Interim General Manager from 2021 to 2022, based in Manati, Puerto Rico. In these roles, Brian played a pivotal role in organizational leadership and operational management.
Experience at Merck
Brian Unangst worked at Merck from 2007 to 2014, where he held various positions in Operations. His tenure included roles such as Manufacturing Area Head and Associate Director, all located in West Point, PA. Brian’s leadership was instrumental in operational management and he received the 2012 Merck Sigma Award for implementing a breakthrough lean change in a large vaccine manufacturing facility.
Educational Background
Brian Unangst earned his Bachelor of Science degree in Biology from Moravian University, studying from 1997 to 2000. Prior to that, he attended Lehigh Carbon Community College for a year, where he also studied Biology. His educational background laid the foundation for his extensive career in the pharmaceutical and biotech industries.
Technical and Operational Expertise
Brian Unangst possesses extensive experience in both upstream and downstream commercial production, including culture media, vaccines, pharmaceuticals, and biologics. He has hands-on production experience as a start-up supervisor and has managed significant manufacturing and technical organizations. His expertise spans a wide range of technologies, including fermentation, mammalian cell culture, chromatography, TFF, lyophilization, and more.